Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Molecular Diagnosis & Therapy|November 11, 2025
Clinical Utility of an RNA-based Gene Fusion Assay in Sarcoma for Diagnosis and Management: Experience in an Australian LaboratoryAdel Shahnam, Catherine Mitchell, Christopher R McEvoy, et al.
Cancer Chemotherapy and Pharmacology|April 12, 2011
Dose-escalating and pharmacological study of bortezomib in adult cancer patients with impaired renal function: a National Cancer Institute Organ Dysfunction Working Group StudyTiciana B Leal, Scot C Remick, Chris H Takimoto, et al.
Histopathology|May 13, 2010
High Notch1 protein expression is an early event in breast cancer development and is associated with the HER-2 molecular subtypeSarah J Zardawi, Ibrahim Zardawi, Catriona M McNeil, et al.
Science (New York, N.Y.)|January 9, 2025
Impacts of EPA's finalized power plant greenhouse gas standardsJohn Bistline, Aaron Bergman, Geoffrey Blanford, et al.
Frontiers in Neurology|November 23, 2020
Plasmin Generation Potential and Recanalization in Acute Ischaemic Stroke; an Observational Cohort Study of Stroke Biobank SamplesThomas Lillicrap, Charithani B Keragala, Dominik F Draxler, et al.
Science (New York, N.Y.)|June 29, 2023
Emissions and energy impacts of the Inflation Reduction ActJohn Bistline, Geoffrey Blanford, Maxwell Brown, et al.
JCO Precision Oncology|February 1, 2022
Clinical Utility of Real-Time Targeted Molecular Profiling in the Clinical Management of Ovarian Cancer: The ALLOCATE StudyOlga Kondrashova, Gwo-Yaw Ho, George Au-Yeung, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 4, 2023
Targeting homologous recombination deficiency in uterine leiomyosarcomaGenevieve Dall, Cassandra J Vandenberg, Ksenija Nesic, et al.
Nature Genetics|February 28, 2023
Multiomic analysis of homologous recombination-deficient end-stage high-grade serous ovarian cancerNikki L Burdett, Madelynne O Willis, Kathryn Alsop, et al.
Histopathology|March 31, 2023
BRCA1 and BRCA2 carriers with breast, ovarian and prostate cancer demonstrate a different pattern of metastatic disease compared with non-carriers: results from a rapid autopsy programmeHeather Thorne, Lisa Devereux, Jason Li, et al.
Pageof 8